Motivation Four decades after liberalization, Tanzania's economy remains locked in a low‐productivity structure: manufacturing is small, informality is close to universal, and structural transformation has stalled. Where the price of formality exceeds its gains, informality persists as an equilibrium rather than as evasion. Explanations typically focus on firms; the architecture of the state's own regulatory apparatus is rarely studied in its own right. Purpose The article shifts the unit of analysis from the firm to the regulatory body. It asks how Tanzania's regulatory estate is configured, funded, and interconnected, and whether that configuration is itself a constraint on formalization and structural transformation. Approach and methods The study builds the first complete and classified census of the bodies that regulate firms in Tanzania: 111 statutory bodies and eight ministry divisions or council functions with binding powers, 119 across 23 sectors, each placed in a Regulatory Ecosystem Matrix of Institutions and examined through a uniform 14‐step review built entirely from the public record. Findings The estate is well founded in law but disjointed in practice. Mandates overlap; approvals stack into repeated steps that raise the price of formality; financing is uneven and in places extractive, with a formalization gateway that raises more than it costs to run; bodies are connected for payments yet siloed for data; and the estate follows inherited administrative lines rather than present strategy. Firm‐side evidence corroborates the census: individual gates are quick, but the cumulative encounter runs well above the regional norm. Policy implications The reform implied is reconfiguration, not dismantling: an owner of the estate's coherence, assigned now and entrenched in law, holding the obligation to share data; targeted consolidation; fees capped to the cost of service; and a shared data rail. Because regulatory architecture can be re‐wired within a single planning cycle, it is a first‐order and tractable instrument of development policy.
No takes yet. Share an insight, caveat, or question.
Andrew Temu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: